Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Current Ratio Over TimeFair Value
Percentile Rank83
3Y CAGR+28.2%
5Y CAGR+13.7%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
+28.2%/yr
Annual compound
5Y CAGR
+13.7%/yr
Recent acceleration
Percentile
P83
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineFair Value
PeriodValueYoY Change
20258.61-44.1%
202415.39+135.8%
20236.53+59.8%
20224.08-51.4%
20218.41+85.6%
20204.53+117.5%
20192.08-